In Vitro and in Vivo Modulation of Alternative Splicing by the Biguanide Metformin

Molecular Therapy Nucleic Acids

Volumn 4, Issue , 2015, Pages

  Laustriat, Delphine ^a   Gide, Jacqueline ^b   Barrault, Laetitia ^c   Chautard, Emilie ^d   Benoit, Clara ^f   Auboeuf, Didier ^g   Boland, Anne ^h   Battail, Christophe ⁱ   Artiguenave, François ^j   Deleuze, Jean François ^a   Bénit, Paule ^a   Rustin, Pierre ^a   Franc, Sylvia ^f   Charpentier, Guillaume ^g   Furling, Denis ^h   Bassez, Guillaume ⁱ   Nissan, Xavier ^a   Martinat, Cécile ^a   Peschanski, Marc ^b   Baghdoyan, Sandrine ^j   Chan, Amy ^d   Liebow, Abigail ^e   Yasuda, Makiko ^f   Gan, Lin ^g   Racie, Tim ^h   Maier, Martin ⁱ   Kuchimanchi, Satya ^b   Foster, Don ^a   Milstein, Stuart ^b   Charisse, Klaus ^c   Sehgal, Alfica ^d   Manoharan, Muthiah ^e   Meyers, Rachel ^f   Fitzgerald, Kevin ^g   Simon, Amy ^h   Desnick, Robert J ⁱ   Querbes, William ^a   more..

^a CECS/AFM   (France)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITÉ LYON 1   (France)

^d CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^h Sorbonne Université   (France)

ⁱ UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^j I Stem   (France)

more..

Author keywords

alternative splicing; AMPK; Metformin; myotonic dystrophy type 1; RBM3

Indexed keywords

ADENYLATE KINASE; METFORMIN; RNA; RNA BINDING PROTEIN; RNA BINDING PROTEIN RBM3; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESODERMAL CELL; MYOBLAST; MYOTONIC DYSTROPHY; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; SPLICING DEFECT;

EID: 84946197868     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2015.36     Document Type: Article

References (62)

1. Cooper, TA, Wan, L and Dreyfuss, G (2009). RNA and disease. Cell 136: 777-793
2. Keren, H, Lev-Maor, G and Ast, G (2010). Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 11: 345-355
3. Oana, K, Oma, Y, Suo, S, Takahashi, MP, Nishino, I, Takeda, S et al. (2013). Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice. Sci Rep 3: 2142
4. Younis, I, Berg, M, Kaida, D, Dittmar, K, Wang, C and Dreyfuss, G (2010). Rapid-response splicing reporter screens identify differential regulators of constitutive and alternative splicing. Mol Cell Biol 30: 1718-1728
5. Stoilov, P, Lin, CH, Damoiseaux, R, Nikolic, J and Black, DL (2008). A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci USA 105: 11218-11223
6. Warf, MB, Nakamori, M, Matthys, CM, Thornton, CA and Berglund, JA (2009). Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci USA 106: 18551-18556
7. Larsson, O, Morita, M, Topisirovic, I, Alain, T, Blouin, MJ, Pollak, M et al. (2012). Distinct perturbation of the translatome by the antidiabetic drug metformin. Proc Natl Acad Sci USA 109: 8977-8982
8. Kouki, T, Takasu, N, Nakachi, A, Tamanaha, T, Komiya, I and Tawata, M (2005). Low-dose metformin improves hyperglycaemia related to myotonic dystrophy. Diabet Med 22: 346-347
9. Ho, TH, Charlet-B, N, Poulos, MG, Singh, G, Swanson, MS and Cooper, TA (2004). Muscleblind proteins regulate alternative splicing. EMBO J 23: 3103-3112
10. Kanadia, RN, Johnstone, KA, Mankodi, A, Lungu, C, Thornton, CA, Esson, D et al. (2003). A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980
11. Miller, JW, Urbinati, CR, Teng-Umnuay, P, Stenberg, MG, Byrne, BJ, Thornton, CA et al. (2000). Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19: 4439-4448
12. Brook, JD, McCurrach, ME, Harley, HG, Buckler, AJ, Church, D, Aburatani, H et al. (1992). Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69: 385
13. Fu, YH, Pizzuti, A, Fenwick, RG Jr, King, J, Rajnarayan, S, Dunne, PW et al. (1992). An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258
14. Mahadevan, M, Tsilfidis, C, Sabourin, L, Shutler, G, Amemiya, C, Jansen, G et al. (1992). Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255: 1253-1255
15. Kuyumcu-Martinez, NM, Wang, GS and Cooper, TA (2007). Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 28: 68-78
16. Fugier, C, Klein, AF, Hammer, C, Vassilopoulos, S, Ivarsson, Y, Toussaint, A et al. (2011). Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med 17: 720-725
17. Charlet-B, N, Savkur, RS, Singh, G, Philips, AV, Grice, EA and Cooper, TA (2002). Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-53
18. Mankodi, A, Takahashi, MP, Jiang, H, Beck, CL, Bowers, WJ, Moxley, RT et al. (2002). Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10: 35-44
19. Marteyn, A, Maury, Y, Gauthier, MM, Lecuyer, C, Vernet, R, Denis, JA et al. (2011). Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell 8: 434-444
20. Denis, JA, Gauthier, M, Rachdi, L, Aubert, S, Giraud-Triboult, K, Poydenot, P et al. (2013). mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1. J Cell Sci 126(Pt 8): 1763-1772
21. Gauthier, M, Marteyn, A, Denis, JA, Cailleret, M, Giraud-Triboult, K, Aubert, S et al. (2013). A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1. Hum Mol Genet 22: 5188-5198
22. Holt, I, Mittal, S, Furling, D, Butler-Browne, GS, Brook, JD and Morris, GE (2007). Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cells 12: 1035-1048
23. Whelan, RS, Konstantinidis, K, Wei, AC, Chen, Y, Reyna, DE, Jha, S et al. (2012). Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci USA 109: 6566-6571
24. Chinnaiyan, AM, Tepper, CG, Seldin, MF, O'Rourke, K, Kischkel, FC, Hellbardt, S et al. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271: 4961-4965
25. Philips, AV, Timchenko, LT and Cooper, TA (1998). Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741
26. Kino, Y, Washizu, C, Oma, Y, Onishi, H, Nezu, Y, Sasagawa, N et al. (2009). MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res 37: 6477-6490
27. Durand, S, Cougot, N, Mahuteau-Betzer, F, Nguyen, CH, Grierson, DS, Bertrand, E et al. (2007). Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J Cell Biol 178: 1145-1160
28. El-Mir, MY, Nogueira, V, Fontaine, E, Averet, N, Rigoulet, M and Leverve, X (2000). Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275: 223-228
29. Zhou, G, Myers, R, Li, Y, Chen, Y, Shen, X, Fenyk-Melody, J et al. (2001). Role of AMP-Activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174
30. Nakamori, M, Sobczak, K, Puwanant, A, Welle, S, Eichinger, K, Pandya, S et al. (2013). Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol 74: 862-872
31. Gabut, M, Samavarchi-Tehrani, P, Wang, X, Slobodeniuc, V, O'Hanlon, D, Sung, HK et al. (2011). An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132-146
32. Anczukow, O, Rosenberg, AZ, Akerman, M, Das, S, Zhan, L, Karni, R et al. (2012). The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat Struct Mol Biol 19: 220-228
33. Pihlajamaki, J, Lerin, C, Itkonen, P, Boes, T, Floss, T, Schroeder, J et al. (2011). Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis. Cell Metab 14: 208-218
34. Naryshkin, NA, Weetall, M, Dakka, A, Narasimhan, J, Zhao, X, Feng, Z et al. (2014). Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science 345: 688-693
35. Anderson, ES, Lin, CH, Xiao, X, Stoilov, P, Burge, CB and Black, DL (2012). The cardiotonic steroid digitoxin regulates alternative splicing through depletion of the splicing factors SRSF3 and TRA2B. RNA 18: 1041-1049
36. Dutertre, M, Sanchez, G, De Cian, MC, Barbier, J, Dardenne, E, Gratadou, L et al. (2010). Cotranscriptional exon skipping in the genotoxic stress response. Nat Struct Mol Biol 17: 1358-1366
37. Vivarelli, S, Lenzken, SC, Ruepp, MD, Ranzini, F, Maffioletti, A, Alvarez, R et al. (2013). Paraquat modulates alternative pre-mRNA splicing by modifying the intracellular distribution of SRPK2. PLoS One 8: e61980
38. Quinn, BJ, Dallos, M, Kitagawa, H, Kunnumakkara, AB, Memmott, RM, Hollander, MC et al. (2013). Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signaling. Cancer Prev Res (Phila) 6: 801-810
39. Iglesias, DA, Yates, MS, van der Hoeven, D, Rodkey, TL, Zhang, Q, Co, NN et al. (2013). Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy. Mol Cancer Ther 12: 2847-2856
40. Chettouh, H, Fartoux, L, Aoudjehane, L, Wendum, D, Claperon, A, Chretien, Y et al. (2013). Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors. Cancer Res 73: 3974-3986
41. Du, H, Cline, MS, Osborne, RJ, Tuttle, DL, Clark, TA, Donohue, JP et al. (2010). Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193
42. Wheeler, TM, Leger, AJ, Pandey, SK, MacLeod, AR, Nakamori, M, Cheng, SH et al. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488: 111-115
43. Leger, AJ, Mosquea, LM, Clayton, NP, Wu, IH, Weeden, T, Nelson, CA et al. (2013). Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. Nucleic Acid Ther 23: 109-117
44. Coonrod, LA, Nakamori, M, Wang, W, Carrell, S, Hilton, CL, Bodner, MJ et al. (2013). Reducing levels of toxic RNA with small molecules. ACS Chem Biol 8: 2528-2537
45. Nakamori, M, Kimura, T, Fujimura, H, Takahashi, MP and Sakoda, S (2007). Altered mRNA splicing of dystrophin in type 1 myotonic dystrophy. Muscle Nerve 36: 251-257
46. Jahnke, VE, Van Der Meulen, JH, Johnston, HK, Ghimbovschi, S, Partridge, T, Hoffman, EP et al. (2012). Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model. Skelet Muscle 2: 16
47. Cheng, J, Zhou, T, Liu, C, Shapiro, JP, Brauer, MJ, Kiefer, MC et al. (1994). Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762
48. Cascino, I, Fiucci, G, Papoff, G and Ruberti, G (1995). Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol 154: 2706-2713
49. Paronetto, MP, Bernardis, I, Volpe, E, Bechara, E, Sebestyen, E, Eyras, E et al. (2014). Regulation of FAS exon definition and apoptosis by the Ewing sarcoma protein. Cell Rep 7: 1211-1226
50. Liu, C, Cheng, J and Mountz, JD (1995). Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem J 310 (Pt 3): 957-963
51. Mateizel, I, De Temmerman, N, Ullmann, U, Cauffman, G, Sermon, K, Van de Velde, H et al. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21: 503-511
52. Bolger, AM, Lohse, M and Usadel, B (2014). Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30: 2114-2120
53. Kim, D, Pertea, G, Trapnell, C, Pimentel, H, Kelley, R and Salzberg, SL (2013). TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14: R36
54. DeLuca, DS, Levin, JZ, Sivachenko, A, Fennell, T, Nazaire, MD, Williams, C et al. (2012). RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28: 1530-1532
55. Li, H, Handsaker, B, Wysoker, A, Fennell, T, Ruan, J, Homer, N et al.; 1000 Genome Project Data Processing Subgroup. (2009). The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079
56. Anders, S, Pyl, PT and Huber, W (2014). HTSeq-A Python framework to work with highthroughput sequencing data. Bioinformatics 31: 166-169
57. Anders, S and Huber, W (2010). Differential expression analysis for sequence count data. Genome Biol 11: R106
58. Mallinjoud, P, Villemin, JP, Mortada, H, Polay Espinoza, M, Desmet, FO, Samaan, S et al. (2014). Endothelial, epithelial, and fibroblast cells exhibit specific splicing programs independently of their tissue of origin. Genome Res 24: 511-521
59. Sacomoto, GA, Kielbassa, J, Chikhi, R, Uricaru, R, Antoniou, P, Sagot, MF et al. (2012). KISSPLICE: de-novo calling alternative splicing events from RNA-seq data. BMC Bioinformatics 13 (suppl. 6): S5
60. Pfaffl, M (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45
61. Benit, P, Goncalves, S, Philippe Dassa, E, Briere, JJ, Martin, G and Rustin, P (2006). Three spectrophotometric assays for the measurement of the five respiratory chain complexes in minuscule biological samples. Clin Chim Acta 374: 81-86
62. Rustin, P, Chretien, D, Bourgeron, T, Gerard, B, Rotig, A, Saudubray, JM et al. (1994). Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228: 35-51.